Urinary tract infections are common, obnoxious and in some cases even life endangering. They are most often caused by uropathogenic Escherichia coli. Persistent and seemingly recurrent infections may be caused by bacteria establishing intracellular reservoirs in the urothelial epithelium. A better understanding of the mechanisms involved in the complex interplay between host and pathogens is required for preventing and controlling these infections. A paper in this issue of Laboratory Investigation reports changes in gene expression in urothelial carcinoma cells following infection by uropathogenic bacteria which go along with the activation of DNA methyltransferase 1 and increased methylation at the CDKN2A gene. These pioneer findings should stimulate the further development of in vitro models for studying urothelial infections and prompt more extensive analyses of epigenetic alterations elicited by bacterial infections in the urinary tract.
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THE CHALLENGE OF URINARY TRACT INFECTIONS
A pproximately 150 million cases of urinary tract infections occur worldwide annually. 1 A prominent group among patients are young and otherwise healthy women. Appropriate treatment with antibiotics will cure many cases, but the disease will recur in about 25% of affected persons. Infections are often associated with inflammation and pain, and upon ascending to the kidney may cause pyelonephritis with renal damage and all its dire consequences.
Most commonly, urinary tract infections are caused by uropathogenic Escherichia coli. 2, 3 In order to establish acute or chronic infections, the bacteria have to express specific virulence factors. 4 For instance, they require type I pili (fimbriae) for attaching to receptors on the urothelial surface strongly enough to withstand the shear force of the urinary flow. Research over the last decade has revealed that uropathogenic E. coli invade urothelial cells to replicate therein. Even worse, the bacteria may establish reservoirs that likely serve as prominent sources of seemingly recurrent infections. 5 The interplay between host and pathogen during urinary tract infections is complex and modulated by genetic differences among human patients as well as uropathogenic bacteria. 4, 6 It is now established that both innate and adaptive immune responses contribute to clearance of the bacteria from the urothelial epithelium, but concomitant inflammation accounts for several disease symptoms. 2, 3, 7 Recognition of pathogenic bacteria is achieved, among other mechanisms, by toll-like receptors such as TLR4. 8, 9 The pathogens in turn wield several mechanisms in order to evade or even exploit the defense responses provided the urothelial barrier and the immune system to establish and maintain infections. For instance, an important defense mechanism in the early infection phase is the exfoliation of upper layers of the infected urothelium, including the so-called umbrella cells with bacteria attached or internalized. 2, 3, 7 This per se efficacious protective mechanism has the downside of exposing the underlying layers of the urothelium to more efficient infection.
Although many aspects of the interaction between uropathogenic E. coli and the cells of the urinary tract have been revealed, we are far from a comprehensive understanding of the pathogenic mechanisms involved. Elucidation of these mechanisms is obviously necessary to achieve progress in therapy and metaphylaxis, especially for ameliorating acute symptoms, avoiding 
progression towards renal disease and preventing recurrences.
UROTHELIAL CARCINOMA CELL LINES AS INFECTION MODELS
urothelial cells. They used established urothelial carcinoma cell lines, which are easy to handle and retain features of urothelial differentiation. In fact, the many available cell lines from bladder cancers differ widely in the extent and pattern of urothelial differentiation and may also vary in the expression of pathogen recognition molecules such as TLRs. In particular, some of these cell lines-especially those derived from papillary urothelial tumors-have been reported to undergo stratification and a certain degree of terminal differentiation under certain culture conditions. A more faithful model would be reconstited normal urothelium in culture, which is feasible, if tedious. 11, 12 Therefore, varying and extending the present culture model should have great potential to provide additional insights into pathogenic mechanisms during urothelial infection.
Obviously, the experimental model system can similarly be exploited to analyze bacterial pathogenicity factors. In the present investigation, the authors compared fimbriae-positive E. coli with a strain lacking these attachment structures, which served as one general control throughout their study. Similar comparisons could be extended to other pathogenicity factors relevant to the 'in culture' situation.
EPIGENETICS OF INFECTION AND CARCINOGENESIS IN UROTHELIAL CELLS Tolg et al
10 made a novel intriguing observation using their experimental model. Successful infection led to quite specific changes in gene expression. In particular, however, the authors report an increase in DNA methyltransferase I (DNMT1) expression as well as activity, along with decreased expression of CDKN2A. Accordingly, elevated DNA methylation could be detected in a CpG island of this important tumor suppressor gene. Expression of the DNA repair enzyme MGMT was likewise downregulated, but no change in methylation was detected at this gene. Of note, the change in CDKN2A methylation was relatively slight and it will be important to study a larger number of loci and additional incubation conditions to substantiate this finding. If so, it will be highly interesting to identify the bacterial factors eliciting increased DNMT1 expression and targeting to specific genes. Nevertheless, the observation provides-to my knowledge-the first piece of evidence that infection of urothelial cells by uropathogenic E. coli not only causes activation of innate immune signaling pathways and short-term changes in gene expression, but also may establish permanent epigenetic changes. Conceivably, these marks made by the bacteria might help to shape the cellular environment for persistent infections. If so, the speculation by Tolg et al that they might be used as a biological marker for susceptibility to recurrent infections may be correct.
Alterations of DNA methylation by pathogens are by no means unprecedented. 13 For instance, there is very good evidence that Helicobacter pylori induces such changes in gastric cells.
14 As during infection of urothelial cells by E. coli, the expression of MGMT is also compromised. 15 Aberrant DNA methylation and other disturbances of epigenetic mechanisms initiated by pathogens is thought to contribute to the eventual development of cancer. From this point of view, the increased methylation at the tumor suppressor CDKN2A is particularly intriguing. However, unlike in the case of H. pylori and the gastric epithelium, a causative relationship between bacterial infection and urothelial cancer development is not well supported by epidemiological data. 16, 17 Of note, infection by schistosoma parasites with its associated inflammatory cystitis is a well-known cause of bladder cancer, leading mainly to the otherwise rare squamous cell carcinoma subtype. 18 The only published study on the topic-to my knowledgeindeed found a higher frequency of DNA methylation alterations in these cancers compared with conventional urothelial carcinomas. 19 Moreover, it should be considered that the major mode of inactivation of CDKN2A in urothelial cancers is gene deletion, presumably elicited by chemical carcinogens. 20 Still, the long-term consequences of epigenetic alterations induced by bacterial infections in the urinary tract ought to be evaluated for their potential importance in urothelial carcinogenesis. 
